The Effect of Preserving Inferior Pulmonary Ligamen on Symptom Burden in Thoracoscopic Pneumonectomy

NCT ID: NCT06452680

Last Updated: 2024-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-30

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators conducted a muti-centres randomized controlled clinical trial to explore the effect of preservation of inferior pulmonary ligment compared with dissection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dissection of the inferior pulmonary ligament (IPL) has been a common practice in upper lobectomy to facilitate the expansion of the remaining lung, reduce dead space after resection, and minimize complications such as pleural effusion and pulmonary infection. However, studies have found that IPL dissection does not improve patient outcomes. On the contrary, releasing the restriction may lead to excessive movement of the remaining lobes, resulting in significant changes in bronchial angles and lung volume, which can worsen pulmonary function and increase postoperative symptoms. Most existing studies are retrospective, providing relatively low-level evidence. Moreover, previous research has primarily focused on radiographic outcomes and pulmonary function tests results, while the effect on patients' symptom burden has been largely overlooked. From the patient's perspective, symptom burden might be more significant, reflecting the clinical value of changes in radiographic and functional indices. In this study, the investigators applied patient-reported outcomes to measure symptoms. Combined with pulmonary function results and radiological outcomes, the investigators compared the clinical value of preserving versus dissecting the IPL in upper lobectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Surgical Procedures Patient Reported Outcome Measures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Preservation group

In the preservation group, the IPL was untouched

Group Type EXPERIMENTAL

Preserving IPL during surgery

Intervention Type PROCEDURE

IPL was preserved during surgery

Dissection group

In the dissection group, the IPL was commonly dissected until the inferior pulmonary vein was exposed

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Preserving IPL during surgery

IPL was preserved during surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients underwent upper lobe resection
2. Patients could complete our questionnaires

Exclusion Criteria

1. Previous history of ipsilateral lung surgery
2. Patients who underwent pleurodesis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guangdong Provincial People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

GuiBin Qiao

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guibin Qiao, MD

Role: STUDY_CHAIR

Guangdong Province People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

General Hospital of Southern Theater Command of the Chinese People's Liberation Army

Guangzhou, Guangdong, China

Site Status

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

Site Status

The Affiliated Panyu Central Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Site Status

The First Affiliated Hospital of Guangdong Pharmaceutical University

Guangzhou, Guangdong, China

Site Status

Shantou University Medical College

Shantou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guibin Qiao, MD

Role: CONTACT

13602749153

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xianglin Li

Role: primary

Guibin Qiao

Role: primary

13602749153

Xianglin Li

Role: backup

18550570726

Xianglin Li

Role: primary

Xianglin Li

Role: primary

Xianglin Li

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY2023-804-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.